Virpax Pharmaceuticals Inc (NASDAQ:VRPX) currently has a daily average trading volume of 3.13M but it saw 1027674 shares traded in last market. With a market cap of 3.32M USD, the company’s current market price of $0.41 came falling about -5.90 while comparing to the previous closing price of $0.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.48 and as low as $0.36. In the recent trading on the day, stock has struck highest price mark of $0.39 while lowest mark touched by it was $0.42.
Taking a look at 20-day trading activity of Virpax Pharmaceuticals Inc (VRPX) gives us an average price of $0.5845, while its current price level is -92.51% below from 52-week high level whereas it is 13.16% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6100 while that of 200 days or SMA-200 reads an average of $1.5870. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.93% during that period while stretching the period over a month that increases to 16.80%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 29.62 which implies that the stock is in oversold territory.
Over the week, VRPX’s stock price is moving -14.54% down while it is -42.23% when we observe its performance for the past one month. Year-to-date it is -87.19% down and over the past year, the stock is showing a downside performance of -90.78%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -12.06 beaten by the consensus estimate of -3 for the same. The company is expected to be releasing its next quarterly report in January, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Virpax Pharmaceuticals Inc’s total number of outstanding shares is 8.09M. Company’s return on equity (ROE) at -594.46%. Stock’s beta reads 0.90. Its return on asset (ROA) is -198.45% on average.
